DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Enclomiphene is an investigational drug.
There have been 21 clinical trials for Enclomiphene. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2012.
The most common disease conditions in clinical trials are Hypogonadism, Neoplasm Metastasis, and Infertility, Male. The leading clinical trial sponsors are Repros Therapeutics Inc., Baylor College of Medicine, and Woman's Health University Hospital, Egypt.
Recent Clinical Trials for Enclomiphene
|A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene||Repros Therapeutics Inc.||Phase 2|
|Clomiphene Citrate Plus Cabergoline in Treatment of Polycystic Ovary Syndrome||Woman's Health University Hospital, Egypt||Phase 2|
|Androxal in Male Infertility||Baylor College of Medicine||Phase 2/Phase 3|